title: Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.
abstract: Several hemolytic markers are available to guide the differential diagnosis and to monitor treatment of hemolytic conditions. They include increased reticulocytes, an indicator of marrow compensatory response, elevated lactate dehydrogenase, a marker of intravascular hemolysis, reduced haptoglobin, and unconjugated hyperbilirubinemia. The direct antiglobulin test is the cornerstone of autoimmune forms, and blood smear examination is fundamental in the diagnosis of congenital membrane defects and thrombotic microangiopathies. Marked increase of lactate dehydrogenase and hemosiderinuria are typical of intravascular hemolysis, as observed in paroxysmal nocturnal hemoglobinuria, and hyperferritinemia is associated with chronic hemolysis. Prosthetic valve replacement and stenting are also associated with intravascular and chronic hemolysis. Compensatory reticulocytosis may be inadequate/absent in case of marrow involvement, iron/vitamin deficiency, infections, or autoimmune reaction against bone marrow-precursors. Reticulocytopenia occurs in 20-40% of autoimmune hemolytic anemia cases and is a poor prognostic factor. Increased reticulocytes, lactate dehydrogenase, and bilirubin, as well as reduced haptoglobin, are observed in conditions other than hemolysis that may confound the clinical picture. Hemoglobin defines the clinical severity of hemolysis, and thrombocytopenia suggests a possible thrombotic microangiopathy or Evans' syndrome. A comprehensive clinical and laboratory evaluation is advisable for a correct diagnostic and therapeutic workup of the different hemolytic conditions.
authors.affiliation: U.O. Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Via Francesco Sforza 35, 20100 Milano, Italy.
authors.forename: W
authors.initials: W
authors.lastname: Barcellini
authors.affiliation: U.O. Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Via Francesco Sforza 35, 20100 Milano, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Fattizzo
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D004906:Erythrocyte Count; D006461:Hemolysis; D006801:Humans
chemical_list: D015415:Biomarkers
references.citation: JAMA. 1980 May 16;243(19):1909-11
references.pmid: 7365971
references.citation: Blood. 2014 Nov 6;124(19):2930-6
references.pmid: 25232059
references.citation: Blood. 2014 Oct 30;124(18):2804-11
references.pmid: 25237200
references.citation: Blood. 2010 Sep 16;116(11):1831-8
references.pmid: 20548093
references.citation: J Matern Fetal Neonatal Med. 2012 Oct;25(10):2138-40
references.pmid: 22372758
references.citation: Br J Haematol. 2005 Jul;130(1):11-25
references.pmid: 15982340
references.citation: Blood. 2008 Oct 15;112(8):3099-106
references.pmid: 18535202
references.citation: Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:68-72
references.pmid: 25879992
references.citation: Eur J Clin Invest. 2006 Mar;36(3):202-9
references.pmid: 16506966
references.citation: Expert Rev Hematol. 2015 Oct;8(5):681-91
references.pmid: 26343892
references.citation: Br J Haematol. 2011 May;153(3):309-17
references.pmid: 21385173
references.citation: Transfus Med Hemother. 2012 Jun;39(3):221-223
references.pmid: 22851939
references.citation: Nature. 2001 Jan 11;409(6817):198-201
references.pmid: 11196644
references.citation: J Thorac Cardiovasc Surg. 2002 Mar;123(3):550-6
references.pmid: 11882830
references.citation: Blood. 2009 Oct 8;114(15):3167-72
references.pmid: 19638626
references.citation: Blood. 1987 Mar;69(3):820-6
references.pmid: 3814817
references.citation: Am J Hematol. 2014 Apr;89(4):443-7
references.pmid: 24809098
references.citation: Transfusion. 2009 Feb;49(2):235-42
references.pmid: 18980619
references.citation: Br J Haematol. 2012 Aug;158(3):323-35
references.pmid: 22624596
references.citation: Haematologica. 2008 Sep;93(9):1310-7
references.pmid: 18641031
references.citation: Blood Rev. 2012 May;26(3):107-15
references.pmid: 22330255
references.citation: Adv Hum Genet. 1982;12:189-261, 453-4
references.pmid: 6751044
references.citation: Antioxid Redox Signal. 2013 Jun 10;18(17):2364-74
references.pmid: 22900934
references.citation: Eur J Intern Med. 2011 Jun;22(3):220-9
references.pmid: 21570637
references.citation: Haematologica. 2011 May;96(5):655-63
references.pmid: 21228033
references.citation: Am J Hematol. 2015 Aug;90(8):E149-51
references.pmid: 25963403
references.citation: Am J Med. 1970 Sep;49(3):296-305
references.pmid: 5455561
references.citation: Am J Hematol. 2014 Oct;89(10):E169-75
references.pmid: 25044164
references.citation: Blood. 1981 Jun;57(6):983-99
references.pmid: 7225572